Millions of diabetics inject insulin daily, and millions more are on the path to injections. But Oramed Pharmaceuticals aims to change that reality, with an insulin pill. Currently in clinical trials, the oral insulin capsule could radically change how we treat diabetes, and dramatically change the lives of diabetic patients. Oramed Pharmaceuticals CEO Nadav Kidron explains the technology behind their oral insulin development.
Nadav Kidron-Oramed Pharmaceuticals is Changing The Lives of Diabetic Patients 3.6.18